ED
Global Health EDCTP3 Joint Undertaking (EDCTP3)

Global collaboration action for the development of TB drugs for therapy and chemoprophylaxis in adults and children in sub-Saharan Africa

Funds Phase IIa-and-later clinical trials of new or shorter TB drug and chemoprophylaxis regimens for adults and children in sub-Saharan Africa.

ClosedGlobal Health EDCTP3 Joint Undertaking (EDCTP3)EUAlbaniaArmeniaBosnia and HerzegovinaCanadaFaroe IslandsGeorgiaIcelandIsraelKosovoMoldovaMontenegroNew ZealandNorth MacedoniaNorwaySerbiaSouth KoreaSwitzerlandTunisiaTรผrkiyeUkraineUnited KingdomEgyptMoroccoBJBFBICMCICDEthiopiaSZGAGMGhanaGWGNKenyaLRMWMLMZNENigeriaCGRwandaSenegalSLSOSouth AfricaTanzaniaUgandaZMZW

This is a two-stage Research and Innovation Action run by Global Health EDCTP3. On the full second-stage application, each of the three award criteria -- Excellence, Impact, and Quality and Efficiency of the implementation -- is scored out of 5, with individual thresholds of 4, 4 and 3, and an overall threshold of 12 out of 15; proposals clearing every threshold are funded within budget, with a poโ€ฆ

This call wants clinical trials that push new or improved TB drugs, shorter treatment regimens, or chemoprophylaxis toward registration, including for multidrug- and extensively drug-resistant TB. It also welcomes proposals combining TB post-exposure prophylaxis with leprosy prevention, since the two diseases share transmission routes and drug candidates. Preclinical work, vaccines, diagnostics and monoclonal antibodies are out of scope.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.โ‚ฌ30M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides โ†’
European Commission logo
Scheduled

Clinical trials for advancing innovative interventions for neurodegenerative diseases

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.

MedtechBiotech
โ‚ฌ10MApr'27
Department for Science, Innovation and Technology logo
Open

Life Sciences Transformational R&D Investment Fund (TRIF) Pilot

๐Ÿ‡ฌ๐Ÿ‡งDSIT ยท United Kingdom

Capital grants for large-scale UK life sciences R&D investments.

BiotechMedtech+1
ยฃ5M โ€“ ยฃ25MApr'28
European Commission logo
Scheduled

Mission Soil and Cancer: Living Labs for Carcinogenic Contamination

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds two โ‚ฌ12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.

Climate TechMedtech+2
โ‚ฌ12MSep'27
European Commission logo
Scheduled

Personalised approaches to reduce risks from adverse drug reactions due to multiple medications

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds safer medication management using biomarkers, clinical data and decision support.

MedtechBiotech+1
โ‚ฌ8M โ€“ โ‚ฌ10MApr'27
European Innovation Council logo
Open

EIC Accelerator Challenge: Biotech for Regenerating Agricultural Soils

๐Ÿ‡ช๐Ÿ‡บEIC ยท European Union

Supports scaling deep-tech for soil health, sustainability, and resilience of EU agriculture.

AgritechBiotech+3
โ‚ฌ1M โ€“ โ‚ฌ12.5MNov'26
European Commission logo
Scheduled

Horizon Health: Antibody Therapies for Emerging Viruses

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds โ‚ฌ9โ€“10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.

BiotechMedtech
โ‚ฌ9M โ€“ โ‚ฌ10MApr'27